Iron deficiency following bariatric surgery: a retrospective cohort study.

Iron deficiency is a common consequence of bariatric surgery and frequently leads to anemia. Our study reports the incidence and predictors of iron deficiency, iron deficiency anemia (IDA), and IV iron use after bariatric surgery. We conducted a retrospective study of all adult patients who underwent bariatric surgery from January to December 2012 at the regional bariatric surgery center in Hamilton, Ontario, Canada, and were followed for at least 6 months. Time-to-event data were presented as Kaplan-Meier curves. Cox regression analysis was used to identify outcome predictors. A total of 388 patients met the inclusion criteria. Iron deficiency, IDA, and the use of IV iron were reported in 43%, 16%, and 6% of patients, respectively, with a mean follow-up of 31 months. The cumulative incidence of iron deficiency and IDA increased with longer follow-up, and there was a significant increase in IV iron use starting 3 years after surgery. Malabsorptive procedures (hazard ratio [HR], 1.92; 95% confidence interval [CI], 1.20-3.06; P = .006) and low baseline ferritin (HR, 0.96; 95% CI, 0.95-0.97; P < .001) were associated with an increased risk of iron deficiency. Young age (HR, 0.90; 95% CI, 0.82-0.99; P = .028), baseline anemia (HR, 19.6; 95% CI, 7.85-48.9; P < .001), and low baseline ferritin (HR, 0.96; 95% CI, 0.95-0.98; P < .001) were associated with an increased risk of IDA. Our results suggest that IDA is a delayed consequence of bariatric surgery and that preoperative assessment of patient risk may be possible.

[1]  C. Apovian,et al.  Clinical practice guidelines for the perioperative nutrition, metabolic, and nonsurgical support of patients undergoing bariatric procedures - 2019 update: cosponsored by American Association of Clinical Endocrinologists/American College of Endocrinology, The Obesity Society, American Society for Me , 2019, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

[2]  Emily K. E. McCracken,et al.  Severe anemia after Roux-en-Y gastric bypass: a cause for concern. , 2018, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

[3]  R. Batterham,et al.  Practical Recommendations of the Obesity Management Task Force of the European Association for the Study of Obesity for the Post-Bariatric Surgery Medical Management , 2017, Obesity Facts.

[4]  S. Liatis,et al.  The role of bariatric surgery to treat diabetes: current challenges and perspectives , 2017, BMC Endocrine Disorders.

[5]  A. Kotze,et al.  British Committee for Standards in Haematology Guidelines on the Identification and Management of Pre‐Operative Anaemia , 2015, British journal of haematology.

[6]  M. Eyster,et al.  Anemia and the Need for Intravenous Iron Infusion after Roux-en-Y Gastric Bypass , 2015, Clinical medicine insights. Blood disorders.

[7]  Sungsoo Park,et al.  Anemia, iron and vitamin B12 deficiencies after sleeve gastrectomy compared to Roux-en-Y gastric bypass: a meta-analysis. , 2014, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

[8]  Kara J Kallies,et al.  Incidence, treatment, and outcomes of iron deficiency after laparoscopic Roux-en-Y gastric bypass: a 10-year analysis. , 2014, Journal of the American College of Surgeons.

[9]  C. Barish,et al.  Burden of Iron Deficiency Anemia in a Bariatric Surgery Population in the United States , 2015, Journal of managed care & specialty pharmacy.

[10]  Deepak L. Bhatt,et al.  Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials , 2013, BMJ.

[11]  I. Jáuregui-Lobera.  Iron Deficiency and Bariatric Surgery , 2013, Nutrients.

[12]  M. Olivares,et al.  Heme- and nonheme-iron absorption and iron status 12 mo after sleeve gastrectomy and Roux-en-Y gastric bypass in morbidly obese women. , 2012, The American journal of clinical nutrition.

[13]  M. Woodward,et al.  Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. , 2012, JAMA.

[14]  S. Gortmaker,et al.  Health and economic burden of the projected obesity trends in the USA and the UK , 2011, The Lancet.

[15]  Bing Li,et al.  Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. , 2011, American journal of epidemiology.

[16]  C. Schmid,et al.  A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.

[17]  T. Dwyer,et al.  Obesity and Menstrual Irregularity: Associations With SHBG, Testosterone, and Insulin , 2009, Obesity.

[18]  S. Varma,et al.  Need for parenteral iron therapy after bariatric surgery. , 2008, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

[19]  D. Dietzen,et al.  Clinical utility of the reticulocyte hemoglobin content in the diagnosis of iron deficiency. , 2002, Blood.

[20]  W. McIlroy,et al.  Laboratory diagnosis of iron-deficiency anemia , 1992, Journal of General Internal Medicine.

[21]  R. Ceneviva,et al.  Anemia and iron deficiency before and after bariatric surgery. , 2014, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.